Innovent Biologics, Inc.

HKEX:1801.HK

39.05 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Operating Activities:
Net Income -196.31-196.31-444.382-444.382-69.575-69.575-614.401-614.401-475.234-475.234-862.599-862.599-501.779-501.779-195.114-195.114-304.097-304.097-502.772-502.772-357.203-357.203-2,907.693-2,907.69321.94721.947-177.682-177.682-103.478-103.478
Depreciation & Amortization 99.33599.33591.57261.29693.81293.81275.92775.92762.46762.46756.33256.33244.75344.75314.614.628.21428.21423.73423.73419.4519.4516.16216.16215.24615.24615.37815.37814.54914.549
Deferred Income Tax 000048.44348.443-429.172-429.17250.55300-29.746411.248405.76129.92928.76445.99745.950.90649.888165.501170.1585.4935.499-27.96-29.515-0.717-0.701-4.035-3.955
Stock Based Compensation 148.861148.861173.604173.604113.495113.495104.158104.158130.588130.588131.268131.268119.519119.519123.92123.9277.33177.33153.15253.15223.38423.3845.735.7320.98820.98810.7110.713.9383.938
Change In Working Capital -59.564-59.564414.008414.008-166.463-166.463123.751123.751-136.603-136.603278.272278.272-414.194-414.19425.59125.591-238.352-238.35258.19958.199-211.139-211.139148.426148.42619.77919.77932.37832.378-24.014-24.014
Accounts Receivables -181.525-181.5254.8064.806-220.117-220.117305.69305.69-109.122-109.12217.02517.025-263.539-263.539-47.677-47.677-64.993-64.993-35.131-35.131-86.137-86.137-1.984-1.984-1.769-1.7690000
Change In Inventory 134.565134.565121.294121.29458.17958.17919.32519.325-72.019-72.019-123.652-123.652-197.989-197.989-101.444-101.444-54.27-54.27-63.508-63.508-82.73-82.73-8.571-8.5714.3714.371-10.112-10.112-0.434-0.434
Change In Accounts Payables 000000000000000000000000000000
Other Working Capital -12.604-12.604287.909287.909-4.526-4.526-201.264-201.26444.53844.538384.899384.89947.33447.334174.712174.712-119.09-119.09156.837156.837-42.272-42.272158.981158.98117.17617.17642.4942.49-23.581-23.581
Other Non Cash Items -100.14-100.14150.55180.826-282.715-282.715-245.487-245.48715.43415.434-107.976-107.976243.983243.983248.963248.96365.10165.101-6.363-6.36367.32367.3232,402.7252,402.725-249.221-249.221-2.917-2.917-14.997-14.997
Operating Cash Flow -107.817-107.817385.351385.351-311.446-311.446-556.053-556.053-403.35-403.35-504.703-504.703-507.719-507.719217.96217.96-371.804-371.804-374.051-374.051-458.186-458.186-334.651-334.651-171.263-171.263-122.134-122.134-124.002-124.002
Investing Activities:
Investments In Property Plant And Equipment -349.757-349.757-260.742-260.742-298.951-298.951-233.953-233.953-214.496-214.496-358.656-358.656-174.162-174.162-227.451-227.451-17.061-17.061-112.946-112.946-69.991-69.991-109.635-109.635-46.735-46.735-43.138-43.138-2.348-2.348
Acquisitions Net 00000000000000000000000089.29989.2990000
Purchases Of Investments 000000000000000000000000000000
Sales Maturities Of Investments 000000000000000000000000000000
Other Investing Activites 72.91272.912-601.109-601.109661.471661.471-673.347-673.347404.203404.203-881.908-881.90865.65165.651-1,890.864-1,890.864-456.919-456.919-11.072-11.072-1,090.57-1,090.57274.721274.721219.963219.963122.862122.862-252.104-252.104
Investing Cash Flow -276.845-276.845-861.851-861.851362.52362.52-907.3-907.3189.707189.707-1,240.563-1,240.563-108.511-108.511-2,118.315-2,118.315-473.98-473.98-124.018-124.018-1,160.561-1,160.561165.086165.086262.527262.52779.72479.724-254.452-254.452
Financing Activities:
Debt Repayment 000000000000000000000000000000
Common Stock Issued 000000000000000000000000000000
Common Stock Repurchased 000000000000000000000000000000
Dividends Paid 000000000000000000000000000000
Other Financing Activities -130.407-130.4071,171.2861,171.286122.343122.3431,334.1791,334.179111.863111.863249.857249.8572,251.8242,251.8241,362.9481,362.9481,093.1131,093.1131,060.571,060.57-5.913-5.9131,656.9851,656.985559.947559.947-1.228-1.22845.93145.931
Financing Cash Flow -130.407-130.4071,171.2861,171.286122.343122.3431,334.1791,334.179111.863111.863249.857249.8572,251.8242,251.8241,362.9481,362.9481,093.1131,093.1131,060.571,060.57-5.913-5.9131,656.9851,656.985559.947559.947-1.228-1.22845.93145.931
Other Information:
Effect Of Forex Changes On Cash -0.8-0.811.92911.929-15.368-15.368-38.766-38.76698.09898.098-57.238-57.238-41.332-41.332-308.783-308.78324.04624.0469.5229.5223.1123.1127.9637.96323.95323.953-10.314-10.314-3.142-3.142
Net Change In Cash -515.868-515.868706.714706.714158.05158.05-167.939-1,537.331-3.683-3.683-1,552.647-970.421,013.1461,594.262-846.19-678.0079.876271.376572.023803.728-2,021.026-1,621.5471,495.3831,988.487516.064675.164-53.951-19.16-430.687-335.664
Cash At End Of Period -515.868-515.868706.714706.714158.05158.05-190.062-185.2881,352.043-4.549-1,904.8473,494.2824,464.7021,891.438-1,004.9432,290.552,968.557297.054640.1682,085.4881,281.76-1,896.5771,702.363,522.5751,534.088844.729-64.781272.503291.663-378.835